6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Kidney Failure, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydin, H; Candan, F; Hür, E; Mağden, K; Yildiz, G; Yilmaz, A | 1 |
| Fiorillo, C; Nassi, P; Nediani, C; Oliviero, C; Pacini, A; Rizzuti, G | 1 |
2 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Influence of single hemodialysis session on serum paraoxonase-1, arylesterase activity, total oxıdant status and total antioxidant status.
Topics: Aryldialkylphosphatase; Biomarkers; Carboxylic Ester Hydrolases; Chromans; Female; Humans; Hydrogen Peroxide; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Time Factors | 2014 |
Oxidative stress and antioxidant defenses in renal patients receiving regular haemodialysis.
Topics: Antioxidants; Arteriosclerosis; Chromans; Fatty Acids, Unsaturated; Female; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Reactive Oxygen Species; Renal Dialysis; Risk Factors; Triglycerides | 1998 |